Kodiak Sciences Inc (MEX:KOD)
MXN 749 (0%) Market Cap: 47.40 Bil Enterprise Value: 45.42 Bil PE Ratio: 0 PB Ratio: 22.78 GF Score: 27/100

Kodiak Sciences Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 09:30PM GMT
Release Date Price: MXN428
Anupam Rama
JPMorgan Chase & Co - Analyst

All right. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference.

My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad: Priyanka Grover, Joyce Zhou, and [Rati Pinge].

Our next presenting company is Kodiak. Presenting on behalf of the company, we have CEO, Victor Perlroth. Victor?

Victor Perlroth
Kodiak Sciences Inc - Chairman of the Board, Chief Executive Officer, Co-Founder

Thank you, Anupam.

Well, each year at the JPMorgan, the metronome of the different years. It's great to be here. Thank you.

But I also remember the R&D Day that Kodiak had in July of last year. I think at that time I said I couldn't be more excited and enthusiastic about what we had in front of us. Now, looking six months later, we've made tremendous progress on the plans that we articulated at that time.

I think what I'd also like to say is, many good things that could have happened did happen and many bad things that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot